Manufactured by Janssen, a subsidiary of Johnson & Johnson, Risperdal is an antipsychotic drug originally formulated to treat schizophrenia.
Zofran and Risperdal’s Off-Label Use
Many drugs are thoroughly tested by both pharmaceutical companies, helping ensure their safety during patient use.
Risperdal Manufacturers Docked Again For Failure-to-Warn
A trial in the Philadelphia Court of Common Pleas reached another verdict on a case concerning Johnson & Johnson’s drug Risperdal on Friday, March 20, ruling that while the company failed to adequately warn about a major side effect, it would not award damages to plaintiff William Cirba.
Johnson & Johnson to Pay $136 Million Risperidone Penalty
On Feb. 26, 2015, South Carolina’s Supreme Court ordered Johnson & Johnson to pay $136 million is Risperdal lawsuit penalties.
Risperdal Gynecomastia Lawsuits Are Back on the Rise
Risperdal, an antipsychotic developed by the Janssen brand of Johnson & Johnson, has long been approved by the Food and Drug Administration for schizophrenia.
Xarelto Complications Surpass the Competition
Xarelto is a fairly new drug on the market, and it’s a blood thinner that helps prevent the risk of stroke.